Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use
- PMID: 10383554
- PMCID: PMC2014872
- DOI: 10.1046/j.1365-2125.1999.00981.x
Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use
Abstract
Aims: To evaluate the activity of the European Medicines Evaluation Agency with regard to the registration for paediatric use of new medicines granted a marketing authorization.
Methods: European Public Assessment Reports published on the Internet from January 95 until April 98 have been analysed using the browser Microsoft Explorer and the software Adobe Acrobat Reader.
Results: Of the 45 new substances licensed since January 95, 29 (64%) were of possible use in children but only 10 were licensed for paediatric use. For the 19 drugs of possible use in children, but not approved for such a use, in nine instances (47%) their summary of product characteristics reported that their use in children has not been established.
Conclusions: A change of practice by pharmaceutical companies and regulatory authorities is imperative so that children are not precluded from having the same rights to medicines as adults.
References
-
- American Academy of Pediatric Committee on Drugs. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. Pediatrics. 1996;98:143–145. - PubMed
-
- Turner S, Nunn AJ, Choonara I. Unlicensed drug use in children in the UK. Paediatr Perinat Drug Ther. 1997;1:52–55.
-
- Note for guidance on clinical investigation of medicinal products in children. London: Medicines Control Agency; 1997.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous